Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells

J Cell Sci. 2010 Apr 15;123(Pt 8):1295-305. doi: 10.1242/jcs.061002. Epub 2010 Mar 23.

Abstract

Mutations in the p53 tumour suppressor gene are associated clinically with tumour progression and metastasis. Downregulation of the E-cadherin cell-cell adhesion molecule is a key event for epithelial to mesenchymal transition (EMT) in tumour progression. Here, we show that wild-type p53 induced to adopt a mutant conformation, and hot-spot p53 mutants, which are both transcriptionally inactive, downregulate E-cadherin expression in the colon carcinoma cell line HCT116. Downregulation of E-cadherin occurred concomitantly with the upregulation of Slug and Zeb-1, transcriptional factors known to repress E-cadherin gene expression. In addition, knockdown of Slug and Zeb-1 expression diminished p53-mediated E-cadherin repression. Knocking down endogenous mutant p53 in MDA-MB-231 and SW620 cancer cell lines lacking E-cadherin protein restored the expression of E-cadherin. Complete loss of E-cadherin expression in HCT116 cells induced morphological alterations along with upregulation of vimentin, a mesenchymal marker. These changes characteristic of the EMT phenotype were, however, not sufficient to confer invasiveness in a three-dimensional matrix. Downregulation of E-cadherin by mutant p53 was not required to promote the invasive phenotype induced by inactivation of p53. These findings indicate that independent control of E-cadherin expression and cell motility could be essential molecular events in p53 mutant-induced invasive phenotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD
  • Cadherins / genetics*
  • Cadherins / metabolism
  • Cell Line, Tumor
  • Collagen / metabolism
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology*
  • Cyclin-Dependent Kinase Inhibitor p21 / deficiency
  • Down-Regulation / genetics
  • Drug Combinations
  • Epithelium / pathology
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Laminin / metabolism
  • Mesoderm / pathology
  • Mutant Proteins / metabolism
  • Mutation / genetics*
  • Neoplasm Invasiveness
  • Phenotype
  • Proteoglycans / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reproducibility of Results
  • Transcription, Genetic
  • Transcriptional Activation / genetics
  • Tumor Suppressor Protein p53 / genetics*
  • Tumor Suppressor Protein p53 / metabolism*
  • Vimentin / genetics
  • Vimentin / metabolism

Substances

  • Antigens, CD
  • CDH1 protein, human
  • Cadherins
  • Cyclin-Dependent Kinase Inhibitor p21
  • Drug Combinations
  • Laminin
  • Mutant Proteins
  • Proteoglycans
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • Vimentin
  • matrigel
  • Collagen